We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Medical Imaging Health IT Point of Care Business Focus

Innovative Injectable Gel Accelerates Tissue Healing

By HospiMedica International staff writers
Posted on 17 Jun 2015
Image: Tissue infiltrates the injectable MAP spheres gel fills, promoting regeneration (Photo courtesy of UCLA).
Image: Tissue infiltrates the injectable MAP spheres gel fills, promoting regeneration (Photo courtesy of UCLA).
A new hydrogel creates an instant scaffold of microporous annealed particles (MAP) that allows tissue regeneration to form within its cavities.

Developed by researchers at the University of California, Los Angeles (UCLA; USA), the injected hydrogel—filled with the microscopic synthetic polymer MAP spheres, each about the width of a human hair—forms a packed cluster that completely fills the wound cavity. New tissue quickly grows into the voids between the microspheres; as the MAP spheres degrade into the body, a matrix of repair tissue is left where the wound once was. New tissue then continues to grow until the wound is completely healed.

The researchers succeeded in demonstrating that the MAP hydrogel can promote the growth of new cells and formation of networks of connected cells at previously unseen rates. During in vivo tests, the researchers observed significant tissue regeneration in the first 48 hours, with much more healing over five days compared to other materials in use today. According to the researchers, the combination of microporosity and injectability will enable novel routes to tissue regeneration. The study was published on June 2, 2015, in Nature Materials.

“The beauty of the MAP gel is that there are no other added growth factors that other technologies require to attract cells into the material,” said study coauthor Westbrook Weaver, PhD, of the UCLA Henry Samueli School of Engineering and Applied Science. “The geometry of the MAP gel networks entices cells to migrate into the gel without the need for anything other than a cell adhesive peptide, so that the cells can grab onto the gels.”

Related Links:

University of California Los Angeles


Gold Member
12-Channel ECG
CM1200B
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Immobilization System
Cranial 4Pi Immobilization
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter

Channels

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Annotation platform for pixel-level labeling of free-text findings in 3D chest CT. (Baharoon M, Luo L, Moritz M, et al. ReXGroundingCT: A 3D chest CT dataset for segmentation of findings from free-text reports. NEJM AI. 2026;3(7). doi:10.1056/AIdbp2501220.)

Public Chest CT Dataset Supports Explainable AI in Diagnostic Radiology

Chest computed tomography scans generate complex three-dimensional images that can be difficult for artificial intelligence systems to explain clearly. Clinicians need to verify AI findings before using... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more